Clinical Trials at TMH
A clinical trials program is an essential part of a true cancer center. All of the current treatments for oncology patients today have been developed from yesterday’s trials. Our program enables patients in our community to receive potential direct benefit of new drugs and treatment pathways while sleeping in their own bed at night, but also indirectly builds the science for future patients who may be their loved ones.
We are always on the lookout for new and exciting clinical trials to offer. Currently, we are looking to expand our program into pancreatic cancer, colon cancer and to offer more trials for lung and breast cancer patients.
Lung Cancer Trials
NRG-LU002: this trial is looking for patients who have stage IV Non-Small Cell lung cancer. This trial is looking to investigate if there is added benefit to including radiation therapy to the current standard treatment. The trial will see if this addition will keep the cancer from growing or coming back as quickly. Learn More
Cypress 1: this trial is looking for patients who have stage IV Non-Small Cell Lung Cancer who has also have a high PD-L1 expression and have not yet been treated. This study uses a new medication in combination with standard immunotherapy in hopes of creating an increased response to the treatment. Learn More
Cypress 2: this trial is for patients who have previously been treated for Non-Small Cell Lung Cancer who have progressed to stage IV and have low PD-L1 expression. This study uses a new medication in combination with standard immunotherapy in hopes of creating an increased response to the treatment. Learn More.
Cervical Cancer Trials
AIM2CERV: this trial is looking for patients with high risk locally advanced cervical cancer. The study will evaluate a new immunotherapy drug for its safety and ability to prevent or delay the cancer from coming back. This study includes a 1-year treatment period, after the initial treatment is completed, and a 5 year follow-up period. Learn More.
Breast Cancer Trials
NRG-BR003: this trial is for newly diagnosed Triple Negative Breast Cancer. We are doing this to see if adding one more drug to the current treatment will keep your cancer from growing or coming back as quickly. Learn More.
MonarchE: this trial is for breast cancer patients with hormone positive, HER2 negative breast cancer. This trial is looking to see if the addition of a new medication to standard endocrine therapy, after initial surgery and treatment is completed, may lower the chances of cancer returning. Learn More.
We are now a participant in the nationwide Cancer Experience Registry. This is an online initiative to understand the experiences of those impacted by a cancer diagnosis. The Cancer Experience Registry is open to anyone who has been diagnosed with cancer—as well as those relatives or friends who assist with their care. The information from the Cancer Experience Registry helps us identify the issues that are more important to you and use that information to fill the gaps in care and deliver improved services to the cancer community. People impacted by cancer—patients and caregivers—are experts in their needs and experiences. The Cancer Experience Registry puts the patient experience and patient voice at the center of the cancer conversation. Register for this study.